Lung Cancer Liquid Biopsy Market Size, Share, Growth, Forecast 2034
Lung Cancer Liquid Biopsy Market By Technology Type (Circulating Tumor Cells, Circulating Tumor DNA, Exosomes, and Circulating RNA), By Application (Early Detection, Treatment Selection, Therapy Monitoring, and Recurrence Detection), By Distribution Channel (Hospitals, Diagnostic Centers, Research Institutes, and Point-of-Care Testing), By End-User (Oncologists, Pathologists, Researchers, and Patients), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 215 Report Code: ZMR-9678
Published Date: Jul-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1.02 Billion | USD 3.54 Billion | 13.20% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Lung Cancer Liquid Biopsy Market, (2025 - 2034) (USD Billion )
- 2.2 Global Lung Cancer Liquid Biopsy Market : snapshot
- Chapter 3. Global Lung Cancer Liquid Biopsy Market - Industry Analysis
- 3.1 Lung Cancer Liquid Biopsy Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increasing lung cancer prevalence
- 3.3 Market Restraints
- 3.3.1. High costs and reimbursement challenges
- 3.4 Market Opportunities
- 3.4.1. Expanding applications in treatment monitoring
- 3.5 Market Challenges
- 3.5.1. Technical limitations and standardization issues
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Technology Type
- 3.7.2 Market attractiveness analysis By Application
- 3.7.3 Market attractiveness analysis By Distribution Channel
- 3.7.4 Market attractiveness analysis By End User
- Chapter 4. Global Lung Cancer Liquid Biopsy Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Lung Cancer Liquid Biopsy Market: company market share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Lung Cancer Liquid Biopsy Market - Technology Type Analysis
- 5.1 Global Lung Cancer Liquid Biopsy Market overview: By Technology Type
- 5.1.1 Global Lung Cancer Liquid Biopsy Market share, By Technology Type, 2024 and 2034
- 5.2 Circulating Tumor Cells
- 5.2.1 Global Lung Cancer Liquid Biopsy Market by Circulating Tumor Cells, 2025 - 2034 (USD Billion )
- 5.3 Circulating Tumor DNA
- 5.3.1 Global Lung Cancer Liquid Biopsy Market by Circulating Tumor DNA, 2025 - 2034 (USD Billion )
- 5.4 Exosomes
- 5.4.1 Global Lung Cancer Liquid Biopsy Market by Exosomes, 2025 - 2034 (USD Billion )
- 5.5 Circulating RNA
- 5.5.1 Global Lung Cancer Liquid Biopsy Market by Circulating RNA, 2025 - 2034 (USD Billion )
- 5.1 Global Lung Cancer Liquid Biopsy Market overview: By Technology Type
- Chapter 6. Global Lung Cancer Liquid Biopsy Market - Application Analysis
- 6.1 Global Lung Cancer Liquid Biopsy Market overview: By Application
- 6.1.1 Global Lung Cancer Liquid Biopsy Market share, By Application, 2024 and 2034
- 6.2 Early Detection
- 6.2.1 Global Lung Cancer Liquid Biopsy Market by Early Detection, 2025 - 2034 (USD Billion )
- 6.3 Treatment Selection
- 6.3.1 Global Lung Cancer Liquid Biopsy Market by Treatment Selection, 2025 - 2034 (USD Billion )
- 6.4 Therapy Monitoring
- 6.4.1 Global Lung Cancer Liquid Biopsy Market by Therapy Monitoring, 2025 - 2034 (USD Billion )
- 6.5 Recurrence Detection
- 6.5.1 Global Lung Cancer Liquid Biopsy Market by Recurrence Detection, 2025 - 2034 (USD Billion )
- 6.1 Global Lung Cancer Liquid Biopsy Market overview: By Application
- Chapter 7. Global Lung Cancer Liquid Biopsy Market - Distribution Channel Analysis
- 7.1 Global Lung Cancer Liquid Biopsy Market overview: By Distribution Channel
- 7.1.1 Global Lung Cancer Liquid Biopsy Market share, By Distribution Channel, 2024 and 2034
- 7.2 Hospitals
- 7.2.1 Global Lung Cancer Liquid Biopsy Market by Hospitals, 2025 - 2034 (USD Billion )
- 7.3 Diagnostic Centers
- 7.3.1 Global Lung Cancer Liquid Biopsy Market by Diagnostic Centers, 2025 - 2034 (USD Billion )
- 7.4 Research Institutes
- 7.4.1 Global Lung Cancer Liquid Biopsy Market by Research Institutes, 2025 - 2034 (USD Billion )
- 7.5 Point-of-Care Testing
- 7.5.1 Global Lung Cancer Liquid Biopsy Market by Point-of-Care Testing, 2025 - 2034 (USD Billion )
- 7.1 Global Lung Cancer Liquid Biopsy Market overview: By Distribution Channel
- Chapter 8. Global Lung Cancer Liquid Biopsy Market - End User Analysis
- 8.1 Global Lung Cancer Liquid Biopsy Market overview: By End User
- 8.1.1 Global Lung Cancer Liquid Biopsy Market share, By End User, 2024 and 2034
- 8.2 Oncologists
- 8.2.1 Global Lung Cancer Liquid Biopsy Market by Oncologists, 2025 - 2034 (USD Billion )
- 8.3 Pathologists
- 8.3.1 Global Lung Cancer Liquid Biopsy Market by Pathologists, 2025 - 2034 (USD Billion )
- 8.4 Researchers
- 8.4.1 Global Lung Cancer Liquid Biopsy Market by Researchers, 2025 - 2034 (USD Billion )
- 8.5 Patients
- 8.5.1 Global Lung Cancer Liquid Biopsy Market by Patients, 2025 - 2034 (USD Billion )
- 8.1 Global Lung Cancer Liquid Biopsy Market overview: By End User
- Chapter 9. Lung Cancer Liquid Biopsy Market - Regional Analysis
- 9.1 Global Lung Cancer Liquid Biopsy Market Regional Overview
- 9.2 Global Lung Cancer Liquid Biopsy Market Share, by Region, 2024 & 2034 (USD Billion )
- 9.3. North America
- 9.3.1 North America Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 9.3.1.1 North America Lung Cancer Liquid Biopsy Market, by Country, 2025 - 2034 (USD Billion )
- 9.3.1 North America Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 9.4 North America Lung Cancer Liquid Biopsy Market, by Technology Type, 2025 - 2034
- 9.4.1 North America Lung Cancer Liquid Biopsy Market, by Technology Type, 2025 - 2034 (USD Billion )
- 9.5 North America Lung Cancer Liquid Biopsy Market, by Application, 2025 - 2034
- 9.5.1 North America Lung Cancer Liquid Biopsy Market, by Application, 2025 - 2034 (USD Billion )
- 9.6 North America Lung Cancer Liquid Biopsy Market, by Distribution Channel, 2025 - 2034
- 9.6.1 North America Lung Cancer Liquid Biopsy Market, by Distribution Channel, 2025 - 2034 (USD Billion )
- 9.7 North America Lung Cancer Liquid Biopsy Market, by End User, 2025 - 2034
- 9.7.1 North America Lung Cancer Liquid Biopsy Market, by End User, 2025 - 2034 (USD Billion )
- 9.4. Europe
- 9.4.2 Europe Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 9.4.2.1 Europe Lung Cancer Liquid Biopsy Market, by Country, 2025 - 2034 (USD Billion )
- 9.4.2 Europe Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 9.4 Europe Lung Cancer Liquid Biopsy Market, by Technology Type, 2025 - 2034
- 9.4.1 Europe Lung Cancer Liquid Biopsy Market, by Technology Type, 2025 - 2034 (USD Billion )
- 9.5 Europe Lung Cancer Liquid Biopsy Market, by Application, 2025 - 2034
- 9.5.1 Europe Lung Cancer Liquid Biopsy Market, by Application, 2025 - 2034 (USD Billion )
- 9.6 Europe Lung Cancer Liquid Biopsy Market, by Distribution Channel, 2025 - 2034
- 9.6.1 Europe Lung Cancer Liquid Biopsy Market, by Distribution Channel, 2025 - 2034 (USD Billion )
- 9.7 Europe Lung Cancer Liquid Biopsy Market, by End User, 2025 - 2034
- 9.7.1 Europe Lung Cancer Liquid Biopsy Market, by End User, 2025 - 2034 (USD Billion )
- 9.5. Asia Pacific
- 9.5.3 Asia Pacific Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 9.5.3.1 Asia Pacific Lung Cancer Liquid Biopsy Market, by Country, 2025 - 2034 (USD Billion )
- 9.5.3 Asia Pacific Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 9.4 Asia Pacific Lung Cancer Liquid Biopsy Market, by Technology Type, 2025 - 2034
- 9.4.1 Asia Pacific Lung Cancer Liquid Biopsy Market, by Technology Type, 2025 - 2034 (USD Billion )
- 9.5 Asia Pacific Lung Cancer Liquid Biopsy Market, by Application, 2025 - 2034
- 9.5.1 Asia Pacific Lung Cancer Liquid Biopsy Market, by Application, 2025 - 2034 (USD Billion )
- 9.6 Asia Pacific Lung Cancer Liquid Biopsy Market, by Distribution Channel, 2025 - 2034
- 9.6.1 Asia Pacific Lung Cancer Liquid Biopsy Market, by Distribution Channel, 2025 - 2034 (USD Billion )
- 9.7 Asia Pacific Lung Cancer Liquid Biopsy Market, by End User, 2025 - 2034
- 9.7.1 Asia Pacific Lung Cancer Liquid Biopsy Market, by End User, 2025 - 2034 (USD Billion )
- 9.6. Latin America
- 9.6.4 Latin America Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 9.6.4.1 Latin America Lung Cancer Liquid Biopsy Market, by Country, 2025 - 2034 (USD Billion )
- 9.6.4 Latin America Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 9.4 Latin America Lung Cancer Liquid Biopsy Market, by Technology Type, 2025 - 2034
- 9.4.1 Latin America Lung Cancer Liquid Biopsy Market, by Technology Type, 2025 - 2034 (USD Billion )
- 9.5 Latin America Lung Cancer Liquid Biopsy Market, by Application, 2025 - 2034
- 9.5.1 Latin America Lung Cancer Liquid Biopsy Market, by Application, 2025 - 2034 (USD Billion )
- 9.6 Latin America Lung Cancer Liquid Biopsy Market, by Distribution Channel, 2025 - 2034
- 9.6.1 Latin America Lung Cancer Liquid Biopsy Market, by Distribution Channel, 2025 - 2034 (USD Billion )
- 9.7 Latin America Lung Cancer Liquid Biopsy Market, by End User, 2025 - 2034
- 9.7.1 Latin America Lung Cancer Liquid Biopsy Market, by End User, 2025 - 2034 (USD Billion )
- 9.7. The Middle-East and Africa
- 9.7.5 The Middle-East and Africa Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 9.7.5.1 The Middle-East and Africa Lung Cancer Liquid Biopsy Market, by Country, 2025 - 2034 (USD Billion )
- 9.7.5 The Middle-East and Africa Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 9.4 The Middle-East and Africa Lung Cancer Liquid Biopsy Market, by Technology Type, 2025 - 2034
- 9.4.1 The Middle-East and Africa Lung Cancer Liquid Biopsy Market, by Technology Type, 2025 - 2034 (USD Billion )
- 9.5 The Middle-East and Africa Lung Cancer Liquid Biopsy Market, by Application, 2025 - 2034
- 9.5.1 The Middle-East and Africa Lung Cancer Liquid Biopsy Market, by Application, 2025 - 2034 (USD Billion )
- 9.6 The Middle-East and Africa Lung Cancer Liquid Biopsy Market, by Distribution Channel, 2025 - 2034
- 9.6.1 The Middle-East and Africa Lung Cancer Liquid Biopsy Market, by Distribution Channel, 2025 - 2034 (USD Billion )
- 9.7 The Middle-East and Africa Lung Cancer Liquid Biopsy Market, by End User, 2025 - 2034
- 9.7.1 The Middle-East and Africa Lung Cancer Liquid Biopsy Market, by End User, 2025 - 2034 (USD Billion )
- Chapter 10. Company Profiles
- 10.1 Guardant Health Inc., Roche Diagnostics Ltd., Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Sysmex Corporation, Exact Sciences Corporation, Natera Inc., Foundation Medicine Inc., Personalis Inc., NeoGenomics Laboratories Inc., Biocept Inc., MDxHealth SA, Epigenomics AG., and others.
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.1 Guardant Health Inc., Roche Diagnostics Ltd., Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Sysmex Corporation, Exact Sciences Corporation, Natera Inc., Foundation Medicine Inc., Personalis Inc., NeoGenomics Laboratories Inc., Biocept Inc., MDxHealth SA, Epigenomics AG., and others.
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 4. Porter’s Five Forces Analysis
- 5. Global Lung Cancer Liquid Biopsy Market attractiveness, By Technology Type
- 6. Global Lung Cancer Liquid Biopsy Market attractiveness, By Application
- 7. Global Lung Cancer Liquid Biopsy Market attractiveness, By Distribution Channel
- 8. Global Lung Cancer Liquid Biopsy Market attractiveness, By End User
- 9. Global Lung Cancer Liquid Biopsy Market share by Technology Type, 2025 and 2034 (USD Billion )
- 10. Global Lung Cancer Liquid Biopsy Market by Circulating Tumor Cells, 2025 - 2034 (USD Billion )
- 11. Global Lung Cancer Liquid Biopsy Market by Circulating Tumor DNA, 2025 - 2034 (USD Billion )
- 12. Global Lung Cancer Liquid Biopsy Market by Exosomes, 2025 - 2034 (USD Billion )
- 13. Global Lung Cancer Liquid Biopsy Market by Circulating RNA, 2025 - 2034 (USD Billion )
- 14. Global Lung Cancer Liquid Biopsy Market share by Application, 2025 and 2034 (USD Billion )
- 15. Global Lung Cancer Liquid Biopsy Market by Early Detection, 2025 - 2034 (USD Billion )
- 16. Global Lung Cancer Liquid Biopsy Market by Treatment Selection, 2025 - 2034 (USD Billion )
- 17. Global Lung Cancer Liquid Biopsy Market by Therapy Monitoring, 2025 - 2034 (USD Billion )
- 18. Global Lung Cancer Liquid Biopsy Market by Recurrence Detection, 2025 - 2034 (USD Billion )
- 19. Global Lung Cancer Liquid Biopsy Market share by Distribution Channel, 2025 and 2034 (USD Billion )
- 20. Global Lung Cancer Liquid Biopsy Market by Hospitals, 2025 - 2034 (USD Billion )
- 21. Global Lung Cancer Liquid Biopsy Market by Diagnostic Centers, 2025 - 2034 (USD Billion )
- 22. Global Lung Cancer Liquid Biopsy Market by Research Institutes, 2025 - 2034 (USD Billion )
- 23. Global Lung Cancer Liquid Biopsy Market by Point-of-Care Testing, 2025 - 2034 (USD Billion )
- 24. Global Lung Cancer Liquid Biopsy Market share by End User, 2025 and 2034 (USD Billion )
- 25. Global Lung Cancer Liquid Biopsy Market by Oncologists, 2025 - 2034 (USD Billion )
- 26. Global Lung Cancer Liquid Biopsy Market by Pathologists, 2025 - 2034 (USD Billion )
- 27. Global Lung Cancer Liquid Biopsy Market by Researchers, 2025 - 2034 (USD Billion )
- 28. Global Lung Cancer Liquid Biopsy Market by Patients, 2025 - 2034 (USD Billion )
- 29. Global Lung Cancer Liquid Biopsy Market share, by Region, 2025 and 2034
- 30. North America Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 31. Europe Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 32. Asia Pacific Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 33. Latin America Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
- 34. The Middle-East and Africa Lung Cancer Liquid Biopsy Market, 2025 - 2034 (USD Billion )
Table Of Tables
- 1. Global Lung Cancer Liquid Biopsy Market: Snapshot
- 2. Drivers of the Lung Cancer Liquid Biopsy Market: impact analysis
- 3. North America Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 4. North America Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 5. North America Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 6. North America Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 7. U.S. Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 8. U.S. Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 9. U.S. Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 10. U.S. Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 11. Canada Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 12. Canada Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 13. Canada Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 14. Canada Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 15. Europe Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 16. Europe Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 17. Europe Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 18. Europe Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 19. Germany Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 20. Germany Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 21. Germany Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 22. Germany Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 23. France Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 24. France Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 25. France Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 26. France Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 27. U.K. Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 28. U.K. Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 29. U.K. Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 30. U.K. Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 31. Italy Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 32. Italy Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 33. Italy Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 34. Italy Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 35. Spain Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 36. Spain Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 37. Spain Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 38. Spain Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 39. Rest of Europe Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 40. Rest of Europe Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 41. Rest of Europe Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 42. Rest of Europe Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 43. Asia Pacific Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 44. Asia Pacific Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 45. Asia Pacific Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 46. Asia Pacific Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 47. China Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 48. China Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 49. China Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 50. China Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 51. Japan Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 52. Japan Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 53. Japan Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 54. Japan Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 55. India Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 56. India Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 57. India Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 58. India Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 59. South Korea Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 60. South Korea Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 61. South Korea Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 62. South Korea Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 63. South-East Asia Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 64. South-East Asia Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 65. South-East Asia Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 66. South-East Asia Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 67. Rest of Asia Pacific Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 68. Rest of Asia Pacific Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 69. Rest of Asia Pacific Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 70. Rest of Asia Pacific Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 71. Latin America Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 72. Latin America Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 73. Latin America Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 74. Latin America Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 75. Brazil Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 76. Brazil Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 77. Brazil Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 78. Brazil Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 79. Mexico Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 80. Mexico Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 81. Mexico Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 82. Mexico Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 83. Rest of Latin America Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 84. Rest of Latin America Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 85. Rest of Latin America Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 86. Rest of Latin America Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 87. The Middle-East and Africa Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 88. The Middle-East and Africa Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 89. The Middle-East and Africa Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 90. The Middle-East and Africa Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 91. GCC Countries Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 92. GCC Countries Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 93. GCC Countries Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 94. GCC Countries Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 95. South Africa Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 96. South Africa Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 97. South Africa Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 98. South Africa Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
- 99. Rest of Middle-East Africa Lung Cancer Liquid Biopsy Market revenue, By Technology Type, 2025 - 2034 (USD Billion )
- 100. Rest of Middle-East Africa Lung Cancer Liquid Biopsy Market revenue, By Application, 2025 - 2034 (USD Billion )
- 101. Rest of Middle-East Africa Lung Cancer Liquid Biopsy Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
- 102. Rest of Middle-East Africa Lung Cancer Liquid Biopsy Market revenue, By End User, 2025 - 2034 (USD Billion )
Methodology
FrequentlyAsked Questions
Lung cancer liquid biopsy is a new and advanced way to detect cancer by studying cancer-related markers found in the blood, instead of doing painful tissue biopsies.
The lung cancer liquid biopsy market is expected to be driven by increasing lung cancer prevalence, growing demand for non-invasive diagnostic methods, expanding applications in precision medicine, technological advancements in molecular diagnostics, and rising acceptance of liquid biopsy as a standard care tool.
According to our study, the global lung cancer liquid biopsy market was worth around USD 1.02 billion in 2024 and is predicted to grow to around USD 3.54 billion by 2034.
The CAGR value of the lung cancer liquid biopsy market is expected to be around 13.20% during 2025-2034.
The global lung cancer liquid biopsy market will register the highest revenue contribution from North America during the forecast period.
Key players in the lung cancer liquid biopsy market include Guardant Health Inc., Roche Diagnostics Ltd., Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Sysmex Corporation, Exact Sciences Corporation, Natera Inc., Foundation Medicine Inc., Personalis Inc., NeoGenomics Laboratories Inc., Biocept Inc., MDxHealth SA, and Epigenomics AG.
The report provides a comprehensive analysis of the lung cancer liquid biopsy market, including an in-depth examination of market drivers, restraints, emerging trends, regional dynamics, and future growth prospects. It also examines the competitive dynamics, technology innovations, distribution strategies, and clinical applications that shape the modern healthcare and biotechnology ecosystem.
HappyClients
